Diane Savarese
- Oncology top 5%
- Cancer Treatment and Pharmacology 5
-
- Prostate Cancer Treatment and Research 3
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism 3
- Cancer, Lipids, and Metabolism 3
- Otorhinolaryngology top 10%
- Hematology top 10%
- Multiple Myeloma Research and Treatments 2
-
- CNS Lymphoma Diagnosis and Treatment 2
-
- Glioma Diagnosis and Treatment 2
-
- Cardiac tumors and thrombi 2
Diane Savarese
24 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 88
- Oncology 576
- Pulmonary and Respiratory Medicine 526
- Cancer Research 184
- Otorhinolaryngology 48
- Hematology 82
Countries citing papers authored by Diane Savarese
This map shows the geographic impact of Diane Savarese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diane Savarese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diane Savarese more than expected).
Fields of papers citing papers by Diane Savarese
This network shows the impact of papers produced by Diane Savarese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diane Savarese. The network helps show where Diane Savarese may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Diane Savarese, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2017 | 1 | |
| 3 | 2016 | 22 | |
| 4 | 2011 | 91 | |
| 5 | 2002 | 21 | |
| 6 | 2001 | 46 | |
| 7 | 2001 | 128 | |
| 8 | 2000 | 17 | |
| 9 | 1999 | 49 | |
| 10 | 1999 | 5 | |
| 11 | A phase II study of docetaxel (Taxotere), estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: preliminary results of cancer and leukemia group B Trial 9780. | 1999 | 48 |
| 12 | 1999 | 3 | |
| 13 | 1998 | 56 | |
| 14 | 1997 | 88 | |
| 15 | 1996 | 26 | |
| 16 | 1996 | 10 | |
| 17 | 1995 | 29 | |
| 18 | 1993 | 9 | |
| 19 | Pharmacokinetics of piroxantrone in a phase I trial of piroxantrone and granulocyte-colony stimulating factor. | 1993 | 3 |
| 20 | 1992 | 48 |
About Diane Savarese
Diane Savarese is a scholar working on Cancer Research, Oncology and Critical Care and Intensive Care Medicine, having authored 24 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (5 papers), Cancer, Hypoxia, and Metabolism (3 papers), Cancer, Lipids, and Metabolism (3 papers), Prostate Cancer Treatment and Research (3 papers), CNS Lymphoma Diagnosis and Treatment (2 papers), Glioma Diagnosis and Treatment (2 papers), Cardiac tumors and thrombi (2 papers) and Multiple Myeloma Research and Treatments (2 papers). The work is most often cited by research in Oncology (576 citations), Pulmonary and Respiratory Medicine (526 citations) and Cancer Research (184 citations). Diane Savarese has collaborated with scholars based in United States and Italy. Frequent co-authors include Todd M. Savarese, John T. Mullen, Susan Halabi, Paul A. Godley, Vera Hárs, Paul E. Wischmeyer, Linda T. Vahdat, Jiang Zhong, Nicholas J. Vogelzang and F. Marc Stewart. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.